RIP1 INHIBITOR COMPOUNDS AND METHODS FOR THEIR PREPARATION AND USE
CY1126293T1Undetermined Publication Date: 2026-07-31RIGEL PHARMACEUTICALS INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- CY20231100597T
- Authority / Receiving Office
- CY · CY
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2018-05-03
- Filing Date
- 2023-10-25
- Publication Date
- 2026-07-31
- Estimated Expiration
- 2043-10-25
Abstract
Disclosed herein are kinase inhibitor compounds, such as receptor-interacting protein-1 (RIP1) kinase inhibitor compounds, as well as pharmaceutical compositions and combinations comprising such inhibitor compounds. The disclosed compounds, pharmaceutical compositions and / or combinations can be used to treat or prevent a kinase-related disease or condition, particularly a RIP1-related disease or condition.
Need to check novelty before this filing date? Find Prior Art